NuSkin Enterprises, Inc. (NUS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NUS trades at $5.84 with a market cap of $284.51M and a P/E ratio of 5.18. NUS moved +2.46% today. Year to date, NUS is -39.73%; over the trailing twelve months it is -23.06%. Its 52-week range spans $5.32 to $14.62. Rallies surfaces NUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
NUS financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. NUS recently traded at $5.84. Market cap is $284.51M. P/E ratio is 5.18. Revenue is $1.44B.
| Metric | Value |
|---|---|
| Price | $5.84 |
| Market Cap | $284.51M |
| P/E Ratio | 5.18 |
| EPS | $1.13 |
| Dividend Yield | 0.06% |
| 52-Week High | $14.62 |
| 52-Week Low | $5.32 |
| Volume | 14 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.44B |
| Net Income | $54.52M |
| Gross Margin | 69.31% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.49B | $160.20M | $3.25 |
| 2024 | $1.73B | $-146.59M | $-2.95 |
| 2023 | $1.97B | $8.60M | $0.17 |
| 2022 | $2.23B | $104.78M | $2.10 |
NUS analyst coverage data. Average price target: $0.00.